Medicare Enrolled

Dr. Analisa Arosemena, MD

Ophthalmology · Miami Beach, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
7135 COLLINS AVE APT 1233, Miami Beach, FL 33141
7863757433
In practice since 2006 (19 years)
NPI: 1346346491 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Arosemena from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Arosemena? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Arosemena

Dr. Analisa Arosemena is an ophthalmology in Miami Beach, FL, with 19 years in practice. Based on federal Medicare data, Dr. Arosemena performed 240 Medicare services across 189 unique beneficiaries.

Between the years covered by Open Payments, Dr. Arosemena received a total of $318,839 from 36 pharmaceutical and/or device companies across 788 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Arosemena is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 240 Medicare services$ $318,839 industry payments

Medicare Practice Summary

Medicare Utilization ↗
240
Medicare services
Bottom 10% in FL for ophthalmology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
189
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~13 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Comprehensive eye exam, established patient61$84$165
Visual field test, extended59$29$75
Eye exam, established patient, focused55$64$150
Optic nerve imaging (OCT scan)40$28$75
Ultrasound scan to determine eye length and lens power14$30$125
Cataract surgery with lens implant11$378$2,500
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.6% high complexity
22.5% medium
72.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$318,839
Total received (2018-2024)
Avg $45,548/year across 7 years
Top 2% in FL for ophthalmology
36
Companies
788
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$242,993 (76.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$66,779 (20.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,067 (2.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$121,928
2023
$49,143
2022
$59,550
2021
$37,537
2020
$14,627
2019
$32,468
2018
$3,585

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Alcon Vision LLC
$63,506
ABBVIE INC.
$60,815
Aerie Pharmaceuticals, Inc.
$33,415
Allergan, Inc.
$26,931
Allergan Inc.
$25,882
AbbVie Inc.
$23,279
NEW WORLD MEDICAL,INC.
$21,056
Glaukos Corporation
$16,397
Nova Eye, Inc.
$15,130
Sight Sciences, Inc.
$11,043
Iridex Corporation
$8,610
Ivantis, Inc
$2,670
Harrow Eye, LLC
$2,211
Johnson & Johnson Surgical Vision, Inc.
$1,461
Carl Zeiss Meditec USA, Inc.
$1,408
Sun Pharmaceutical Industries Inc.
$859
SUN PHARMACEUTICAL INDUSTRIES INC.
$702
Oculus Surgical Inc.
$654
Bausch & Lomb Americas Inc.
$521
Thea Pharma Inc.
$472
Dompe US, Inc.
$434
RxSight Inc
$351
Mallinckrodt Hospital Products Inc.
$176
Tarsus Pharmaceuticals, Inc.
$159
Amgen Inc.
$122
Bausch & Lomb, a division of Bausch Health US, LLC
$102
Ocular Therapeutix, Inc.
$85
Oyster Point Pharma, Inc.
$77
Novartis Pharmaceuticals Corporation
$77
EYEVANCE PHARMACEUTICALS LLC
$76
BIOTISSUE HOLDINGS INC.
$38
Takeda Pharmaceuticals U.S.A., Inc.
$36
Alcon Laboratories Inc
$34
Carl Zeiss Meditec, Inc.
$17
TISSUETECH, INC.
$17
Shire North American Group Inc
$16
Top 3 companies account for 49.5% of total payments
Associated products mentioned in payments ›
ACTHAR · ALPHAGAN P · ARGOS · AcrySof IQ PanOptix · Ahmed Glaucoma Valve · BROMSITE · CE-marked KXLA system · CIRRUS HD-OCT · COMBIGAN · Cequa · Clareon · CyPass · DEXTENZA · DUREZOL · DURYSTA · GONIO ready · HYDRUS Microstent · Hydrus · Hydrus Microstent · INFUSE · ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM · IYUZEH · Kahook Dual Blade · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LIVTENCITY · LOTEMAX SM · LUMIGAN · LenSx · MIEBO · None Specified · OMNI · OMNI SURGICAL SYSTEM · OMNI(R) SURGICAL SYSTEM (US) · OXERVATE · PROKERA · PanOptix · RESTASIS · RESTASIS MULTIDOSE · RXSIGHT CONTACT LENS · Radius · Rhopressa · Rocklatan · SION SURGICAL INSTRUMENT · Simbrinza · Streamline · TECNIS IOL · TEPEZZA · TRAVATAN Z · TYRVAYA · Tecnis 1-piece IOL · Tecnis 3-piece IOL · Tecnis IOL · Tecnis Multifocal Family of 1-piece IOLS · VEVYE · VUITY · VYZULTA · XDEMVY · XELPROS · XEN · XEN GLAUCOMA TREATMENT SYSTEM · XIIDRA · iDose · iStent Trabecular Micro-Bypass System Model iS3 · iStent inject Trabecular Micro-Bypass Stent System · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (76%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for ophthalmology in FL.

Equivalent to $132,850 per 100 Medicare services performed
Looking for a ophthalmology in Miami Beach?
Compare ophthalmologys in the Miami Beach area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologys nearby

Geographic Context

Ophthalmologys within 10 mi
374
Per 100K population
13.9
County median income
$68,694
Nearest hospital
MOUNT SINAI MEDICAL CENTER OF FLORIDA, INC
2.4 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Arosemena is a mixed practice specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 2%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Arosemena experienced with comprehensive eye exam, established patient?
Based on Medicare claims data, Dr. Arosemena performed 61 comprehensive eye exam, established patient services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Arosemena receive payments from pharmaceutical companies?
Yes. Dr. Arosemena received a total of $318,839 from 36 companies across 788 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Arosemena's costs compare to other ophthalmologys in Miami Beach?
Dr. Arosemena's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Arosemena) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →